Class II
Terminated
ASPIRIN EC, Tablet, 325 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904201360.
Why: Labeling: Label Mixup: ASPIRIN EC, Tablet, 325 mg may have potentially been mislabeled as one of the following drugs: MULTIVITAMIN/MULTIMINERAL, CHEW Tablet, 0 mg, NDC 58914001460, Pedigree: AD30180_10, EXP: 5/9/2014; DILTIAZEM HCL ER, Capsule, 240 mg, NDC 49884083109, Pedigree: AD52375_1, EXP: 5/17/2014; ASPIRIN, Tablet, 325 mg, NDC 00536330501, Pedigree: W003355, EXP: 6/19/2014; ASPIRIN, Tab
- Company
- Aidapak Services, LLC
Vancouver, WA, United States - Reported
- Jan 29, 2014
- Recall started
- Jul 2, 2013
- Ended
- Feb 7, 2014
- Where sold
- Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
- Amount
- 499 Tablets
- Full product description
- ASPIRIN EC, Tablet, 325 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904201360.
- Lots / codes affected
- ASPIRIN EC, Tablet, 325 mg has the following codes: Pedigree: AD30180_13, EXP: 5/9/2014; Pedigree: AD52378_1, EXP: 5/17/2014; Pedigree: W003356, EXP: 6/19/2014; Pedigree: W003526, EXP: 6/21/2014; Pedigree: AD39588_1, EXP: 5/13/2014.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.